BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...

A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...

Johnson & Johnson’s rebate model aims to address misuse of 340B Program. HRSA’s threats of penalties led J&J to halt the plan, prompting a legal battle to protect its proposed changes. Johnson & ...

WASHINGTON (AP) — Speaker Mike Johnson is beginning the hard fight for his gavel, a weeks-long campaign that starts Wednesday ...

A 46-year-old man accused of making threats that led officials to lock down Spokane City Hall and to cancel City Council ...

Averaging 3+ SPG over the first 10 games of the season. pic.x.com/S0eKbfXlWfSource: Twitter @statmuse What’s the buzz on ...

Johnson & Johnson MedTech announced that the U.S. Food & Drug Administration has approved the Ottava robotic surgical system ...

Johnson & Johnson sued the U.S. Health and Human Services Department on Tuesday, accusing the agency of blocking its plan to ...

Shares of Johnson & Johnson JNJ shed 1.55% to $152.64 Tuesday, on what proved to be an all-around grim trading session for ...

Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some ...

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the ...